Cision PR Newswire

Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy

First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in human skeletal muscle in a monogenic disease. Paired muscle biopsies reveal 3.5- to 5.3-fold increases in sarcolemmal utrophin expression, accompanied by definitive tissue histopathological...

Vatrer Power to Showcase Lithium Golf Cart Battery Conversion Kits at 2026 Golf Carting Expo & Dealer Summit

LAS VEGAS and CHARLESTON, S.C., Oct. 3, 2026 /PRNewswire/ -- Vatrer Power, a provider...

Property Management of Chulalongkorn University Shapes a Sustainable District Through Shared Value and Innovation

BANGKOK, Oct. 3, 2026 /PRNewswire/ -- A thriving district is more than the buildings...

PEA Powers Thailand’s Sustainable Energy Future Through a Brand Built on Trust, Innovation, and Meaningful Impact

BANGKOK, Oct. 3, 2026 /PRNewswire/ -- A trusted brand is built through every interaction,...

Samsung Introduces ‘Gemilang’ Merdeka Promo with Exclusive Rewards Starting Today Until 30 September 2025

KUALA LUMPUR, Malaysia, Aug. 4, 2025 /PRNewswire/ -- As we enter the month of August, Malaysians everywhere are gearing up to celebrate the spirit...

HKBU leads the development of multifunctional nanorobots for precise and effective pollutant degradation and bacterial removal

HONG KONG, Aug. 4, 2025 /PRNewswire/ -- A collaborative research team led by Hong Kong Baptist University (HKBU) has developed a multifunctional nanorobot equipped...

The Westin Singapore Launches Exclusive “Move Well Marathon Package” for SCSM 2025 Participants

SINGAPORE, Aug. 4, 2025 /PRNewswire/ -- In celebration of its third consecutive year as the Official Elite Hotel of the Standard Chartered Singapore Marathon (SCSM), The...

NX Taiwan Awarded Healthy Workplace Certification by “Ministry of Health and Welfare”

- Received High Praise for Promoting Health Management and Contributing to Local Communities - TOKYO, Aug. 4, 2025 /PRNewswire/ -- Nippon Express (Taiwan)...

Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug...